Oxygen Therapy Equipment Market

The Global Oxygen Therapy Equipment Market size was estimated at USD 4.8 billion in 2025 and is projected to reach USD 8.9 billion by 2035, growing at a CAGR of 6.4% from 2026 to 2035. The market continues to attract strategic attention due to the structural expansion of chronic respiratory disease management, aging demographics, post-acute care decentralization, and rising clinical dependence on long-duration oxygen administration across hospital and homecare ecosystems. Oxygen therapy equipment now occupies a critical position within pulmonary care pathways, emergency stabilization infrastructure, and long-term patient monitoring frameworks, making procurement continuity and technology differentiation increasingly material for healthcare providers and investors.

Market Overview

The Oxygen Therapy Equipment Market has evolved from a hospital-centric respiratory support category into a broader care-enablement ecosystem integrated across acute care facilities, ambulatory treatment networks, rehabilitation environments, and home-based chronic disease management models. This transition has materially altered procurement behavior, product design priorities, and distribution economics. Buyers no longer evaluate oxygen therapy systems solely on flow delivery performance; purchasing decisions increasingly incorporate portability, maintenance intervals, digital monitoring compatibility, energy efficiency, and total lifecycle operating cost. As healthcare systems continue shifting treatment duration away from inpatient settings, oxygen therapy equipment manufacturers are being compelled to redesign portfolios around mobility, patient compliance, and decentralized care continuity.

The market also reflects a hybrid maturity profile in which core oxygen delivery technologies remain operationally established, while supporting innovations around miniaturization, telemetry integration, and energy optimization continue reshaping competitive positioning. Executive leadership teams track this market because oxygen delivery has become strategically linked to broader respiratory care infrastructure planning, reimbursement stability, and healthcare resilience policies. Procurement cycles are increasingly tied to long-duration chronic care expansion rather than episodic emergency demand alone. This transition has elevated the strategic importance of service networks, consumable compatibility, and installed-base retention, particularly among providers seeking predictable utilization economics and reduced operational interruptions.

Key Market Drivers & Industrial Demand Dynamics

The sustained expansion of chronic obstructive pulmonary disease, sleep-related respiratory disorders, pulmonary fibrosis, and post-viral respiratory complications continues to underpin long-term demand formation across the Oxygen Therapy Equipment Market. The primary market driver is not solely disease prevalence, but rather the rising duration of oxygen dependency among aging patient populations requiring continuous or intermittent respiratory support. As healthcare systems experience increasing pressure to reduce inpatient occupancy costs, oxygen therapy has progressively shifted toward outpatient and homecare delivery models. This structural migration has increased demand for lightweight concentrators, portable delivery systems, and integrated monitoring solutions capable of supporting patient adherence outside clinical supervision environments. The strategic consequence is that equipment suppliers now compete as continuity-of-care partners rather than commodity hardware vendors.

A second demand catalyst originates from healthcare infrastructure resilience planning following large-scale respiratory emergencies observed across multiple regions. Hospital systems and public health authorities have expanded reserve oxygen delivery capabilities to avoid supply bottlenecks and operational instability during patient surges. This has created sustained procurement demand for centralized oxygen systems, backup delivery platforms, and scalable therapy infrastructure across both developed and emerging healthcare systems. The impact extends beyond emergency preparedness because healthcare administrators now evaluate oxygen therapy equipment through a risk-mitigation framework tied to continuity planning, equipment redundancy, and maintenance responsiveness. Suppliers capable of supporting rapid deployment logistics and servicing flexibility therefore retain stronger negotiating leverage during institutional contracting cycles.

Industrial demand dynamics are also being shaped by reimbursement evolution and payer scrutiny around long-term respiratory care expenditures. Healthcare providers increasingly prioritize devices that reduce hospitalization recurrence, support patient mobility, and improve treatment compliance because reimbursement structures are progressively linked to outcome efficiency rather than treatment volume. This shift has favored equipment categories that combine portability with operational reliability and low servicing intensity. Manufacturers investing in remote diagnostics and usage monitoring capabilities are positioned to strengthen relationships with integrated care networks seeking measurable reductions in readmission exposure. Consequently, the market is becoming less dependent on standalone equipment performance and more influenced by ecosystem integration capabilities.

Another material growth driver stems from demographic transition patterns across both developed and middle-income economies. Aging populations contribute disproportionately to respiratory support demand because pulmonary function deterioration, cardiovascular complications, and mobility limitations frequently require long-term oxygen supplementation. Simultaneously, urban pollution exposure and occupational respiratory risks continue expanding the addressable patient pool across industrializing regions. The resulting demand profile is structurally durable rather than cyclical. This matters strategically because suppliers can justify longer investment horizons in manufacturing localization, distribution partnerships, and after-sales service expansion without relying exclusively on short-term utilization spikes.

Technology convergence is further accelerating replacement cycles within institutional and homecare segments. Older stationary systems are increasingly viewed as operationally restrictive due to high maintenance requirements, energy inefficiency, and limited mobility support. Healthcare providers and homecare agencies are therefore replacing legacy infrastructure with compact, digitally enabled platforms capable of supporting continuous monitoring and predictive maintenance workflows. This replacement-driven demand environment creates favorable economics for premium product positioning while simultaneously increasing competitive pressure on low-cost manufacturers lacking differentiated service capabilities.

Segmentation Analysis

Within the Oxygen Therapy Equipment Market, segmentation

by type remains strategically important because clinical settings, patient mobility requirements, and reimbursement economics vary materially across therapy delivery formats. Oxygen concentrators accounted for the largest share of global demand in 2025 due to their suitability for long-duration therapy, lower recurring supply dependence, and compatibility with homecare treatment models. Concentrators benefit from favorable operational economics because they reduce reliance on cylinder logistics and refill infrastructure, making them particularly attractive for decentralized care systems and regions with fragmented distribution networks. Portable concentrators, in particular, command higher margin realization due to their technological complexity, battery optimization requirements, and strong patient preference for mobility-enabled treatment. By contrast, compressed oxygen cylinders continue to retain relevance in emergency care environments, transportation settings, and regions where electrical infrastructure reliability remains inconsistent. Liquid oxygen systems represented a material minority of demand but maintained strategic importance for high-flow therapy patients requiring continuous oxygen delivery over extended periods.

Demand behavior across equipment types also reflects distinct procurement cycles and switching barriers. Hospital buyers frequently prioritize reliability, flow consistency, and fleet standardization because interoperability and maintenance simplicity directly affect operational continuity. Homecare providers, however, increasingly prioritize patient portability, device weight, noise reduction, and battery endurance because patient adherence materially influences reimbursement outcomes and service retention rates. These differences create segmentation-specific competitive structures in which premium portable devices experience stronger pricing resilience while commodity delivery formats face greater procurement commoditization. Suppliers capable of operating across both institutional and consumer-oriented purchasing environments therefore maintain broader revenue stability and improved installed-base monetization opportunities.

By application, chronic obstructive pulmonary disease management contributed over one-third of total demand in 2025 because long-duration oxygen dependency is highly concentrated within chronic pulmonary disease populations. The application segment exists primarily due to the ongoing clinical requirement for continuous oxygen supplementation to stabilize blood oxygen saturation and reduce hospitalization recurrence risk. Demand within this category is relatively stable across economic cycles because oxygen therapy often represents medically necessary treatment rather than elective intervention. Asthma-related respiratory support, sleep apnea-associated oxygen supplementation, emergency medicine, and post-surgical recovery applications collectively expanded procurement diversity, reducing concentration risk for suppliers. Emergency and critical care applications generally favor high-flow systems and centralized delivery infrastructure, whereas chronic disease management increasingly supports portable and home-use configurations.

Application–level economics differ materially in terms of utilization intensity and service requirements. Acute care applications typically involve higher equipment turnover, accelerated maintenance cycles, and institutional procurement contracts with stringent compliance specifications. Chronic homecare applications, by contrast, prioritize long-duration usability, patient convenience, and remote servicing capabilities. These distinctions shape supplier investment strategies because recurring revenue opportunities are often stronger in long-term homecare ecosystems where maintenance contracts, consumables, and device replacement cycles remain predictable. Switching barriers also vary by application. Hospitals frequently standardize procurement to reduce staff training complexity and maintenance fragmentation, while homecare users demonstrate stronger brand loyalty once device familiarity and portability expectations are established.

By End-user segmentation further clarifies purchasing authority and operational priorities across the Oxygen Therapy Equipment Market. Hospitals and acute care centers accounted for the largest share of procurement activity in 2025 due to centralized oxygen infrastructure requirements, emergency preparedness obligations, and high patient throughput environments. However, homecare settings continue to represent the most strategically influential end-user category because they are reshaping product innovation trajectories and reimbursement alignment strategies. Homecare demand exists because healthcare systems increasingly seek to reduce inpatient treatment durations while maintaining continuity for chronic respiratory patients. This transition has elevated the importance of lightweight systems, user-friendly interfaces, and remote diagnostics integration.

Ambulatory surgical centers, rehabilitation facilities, and specialty respiratory clinics collectively represent an expanding procurement layer positioned between institutional care and fully decentralized home treatment. These facilities often seek equipment configurations that balance portability with higher therapeutic flexibility, creating opportunities for modular systems and multi-setting compatibility. End-user purchasing behavior also differs substantially in contract structure and price sensitivity. Large hospitals typically negotiate long-duration procurement agreements emphasizing service reliability and fleet integration, whereas smaller outpatient networks prioritize acquisition affordability and maintenance simplicity. Suppliers able to customize financing structures and after-sales support according to end-user operational scale retain stronger competitive positioning across fragmented regional markets.

Technology and configuration segmentation is increasingly important because differentiation within the Oxygen Therapy Equipment Market is shifting away from basic oxygen delivery toward integrated patient management capabilities. Continuous flow systems continue to dominate institutional care environments due to their suitability for severe respiratory conditions and uninterrupted therapy requirements. Pulse dose systems, however, are gaining stronger traction within ambulatory and portable care settings because they improve battery efficiency and support patient mobility. The existence of these configurations reflects differing clinical requirements, energy management considerations, and portability trade-offs. Advanced digital integration features, including remote monitoring compatibility and predictive maintenance diagnostics, are becoming increasingly relevant procurement differentiators among healthcare networks focused on utilization transparency and operational continuity.

From an investor perspective, technology-enabled configurations generally support higher gross margin structures due to software integration, service monetization opportunities, and reduced direct comparability with low-cost alternatives. However, these systems also face longer regulatory review cycles and greater post-market support obligations. Suppliers operating within digitally integrated segments therefore require stronger compliance infrastructure and software support capabilities. Despite these operational complexities, technology-enabled configurations are expected to strengthen competitive defensibility because healthcare providers increasingly prioritize continuity monitoring and lifecycle cost visibility over upfront acquisition pricing alone.

Strategic Market Snapshot

The Oxygen Therapy Equipment Market demonstrates characteristics of a structurally resilient healthcare equipment category with moderate pricing power and relatively stable long-term utilization patterns. Demand cyclicality remains lower than many adjacent medical device segments because oxygen therapy is fundamentally linked to medically necessary respiratory stabilization and chronic disease management. However, competitive intensity has increased as procurement teams apply greater scrutiny to lifecycle operating costs, maintenance obligations, and interoperability requirements. Market maturity is evident in core delivery technologies, yet innovation-driven replacement cycles continue supporting portfolio expansion opportunities, particularly in portable and digitally integrated systems.

Buyer–supplier dynamics increasingly favor manufacturers capable of combining hardware reliability with service continuity and regional distribution strength. Large healthcare systems maintain substantial negotiating leverage during procurement consolidation cycles, particularly for standardized fleet purchases. Nevertheless, switching friction remains meaningful due to staff training requirements, maintenance compatibility, and regulatory documentation obligations. This balance has preserved moderate supplier pricing resilience, especially among companies with diversified respiratory care portfolios and established servicing infrastructure.

Value Chain, Cost Structure & Procurement Intelligence

The Oxygen Therapy Equipment value chain is shaped by component sourcing complexity, regulatory compliance intensity, and long-duration servicing obligations. Core production inputs include compressors, molecular sieve materials, valves, pressure regulators, flow control systems, batteries, electronic monitoring components, and specialized plastics. Energy sensitivity remains particularly relevant for concentrator manufacturing because component calibration and testing processes require stable operational environments and precision quality assurance. Supply chain disruptions affecting semiconductor availability, battery sourcing, or medical-grade component certification can materially influence production lead times and procurement continuity.

Procurement cycles vary considerably between institutional buyers and homecare providers. Large healthcare systems frequently operate under multi-year contracts emphasizing maintenance responsiveness, spare-part availability, and compliance documentation continuity. Homecare procurement, by contrast, often involves distributor-led purchasing structures with greater emphasis on portability, patient usability, and servicing turnaround times. Switching friction remains moderate to high because oxygen therapy equipment is deeply integrated into patient treatment continuity and caregiver training processes. Supplier relationship breakpoints typically emerge when maintenance responsiveness deteriorates, consumable compatibility becomes inconsistent, or device reliability affects reimbursement-linked patient outcomes.

Market Restraints & Regulatory Challenges

Despite structurally durable demand conditions, the Oxygen Therapy Equipment Market faces margin pressure arising from reimbursement compression, procurement consolidation, and intensifying competition within standardized equipment categories. Healthcare providers increasingly evaluate acquisition decisions through total-cost-of-ownership frameworks, limiting pricing flexibility for suppliers unable to demonstrate measurable operational efficiencies or patient adherence improvements. This environment disproportionately affects manufacturers competing primarily on hardware pricing without differentiated service capabilities or advanced monitoring integration.

Regulatory obligations also continue expanding across both developed and emerging healthcare markets. Oxygen therapy systems require compliance with stringent safety standards governing oxygen concentration consistency, pressure regulation, electrical reliability, and patient-use compatibility. Portable and digitally connected systems face additional scrutiny related to battery performance, cybersecurity standards, and remote monitoring data integrity. These requirements increase development costs, extend product approval timelines, and raise post-market surveillance obligations. Smaller manufacturers frequently encounter operational strain when attempting to scale internationally due to fragmented certification requirements and localized compliance frameworks.

Operational risk exposure is further amplified by maintenance dependency and service continuity expectations. Equipment failure within long-duration oxygen therapy environments can create immediate clinical consequences, increasing liability sensitivity for suppliers and providers alike. As healthcare systems become more dependent on decentralized care delivery, servicing responsiveness and logistics reliability become increasingly important determinants of competitive positioning. Companies lacking robust regional support infrastructure may therefore struggle to maintain long-term institutional relationships despite offering competitively priced products.

Market Opportunities & Outlook (2026–2035)

The long-term Oxygen Therapy Equipment Market forecast remains supported by structural respiratory care expansion, healthcare decentralization, and replacement-driven technology modernization. Future growth is expected to be increasingly linked to homecare and ambulatory treatment ecosystems rather than solely hospital infrastructure expansion. This distinction is strategically important because homecare-oriented demand generally favors higher-margin portable systems, recurring servicing revenue, and digital monitoring integration opportunities. Suppliers capable of aligning product portfolios with reimbursement-supported outpatient treatment models are therefore positioned to capture stronger long-term profitability.

Regional opportunity patterns will vary according to healthcare infrastructure maturity and respiratory disease burden. Developed healthcare markets are expected to prioritize replacement demand focused on portability, connectivity, and patient adherence optimization. Emerging healthcare systems, by contrast, are likely to emphasize access expansion, oxygen infrastructure development, and broader deployment of cost-efficient concentrator platforms. This divergence creates parallel growth pathways in which premium innovation and scalable affordability can coexist across different procurement environments.

Volume-versus-margin dynamics will remain central to competitive strategy during the forecast period. High-volume standardized equipment categories may experience continued pricing pressure, particularly where procurement consolidation intensifies. However, advanced portable systems, integrated monitoring configurations, and energy-efficient platforms are likely to preserve stronger pricing resilience due to differentiation and lower direct substitutability. Investors and strategy teams therefore increasingly evaluate the market through installed-base monetization potential and service ecosystem strength rather than equipment shipment volume alone.

Regional & Country-Level Strategic Insights

North America accounted for the largest regional share of the global Oxygen Therapy Equipment Market in 2025, supported by established reimbursement systems, extensive homecare infrastructure, and high prevalence of chronic respiratory disorders. The regional market also benefits from elevated adoption of portable and digitally integrated oxygen delivery platforms due to strong outpatient treatment penetration and patient mobility expectations. Healthcare providers across the region increasingly prioritize long-duration therapy management and remote patient monitoring integration, reinforcing demand for advanced oxygen delivery configurations.

Europe continues to represent a strategically stable market characterized by aging populations, mature healthcare systems, and strong regulatory oversight. Procurement behavior within the region increasingly favors energy-efficient systems and long-duration reliability due to sustainability priorities and healthcare budget optimization efforts. Asia Pacific remains the most operationally dynamic region because urban pollution exposure, healthcare infrastructure expansion, and rising chronic disease diagnosis rates are materially expanding the addressable patient population. Latin America and the Middle East & Africa are demonstrating growing procurement activity tied to healthcare access expansion and emergency preparedness investment, although pricing sensitivity and infrastructure variability continue influencing equipment selection patterns.

Technology, Innovation & Derivative Trends

Technology development within the Oxygen Therapy Equipment Market is increasingly centered on portability optimization, energy efficiency enhancement, and integration with remote patient management systems. Compact concentrator architectures and lightweight battery systems are reshaping patient mobility expectations, particularly among long-duration therapy users seeking greater independence and outpatient flexibility. This trend is strategically important because portability improvements directly influence therapy adherence and patient retention within homecare ecosystems.

Innovation priorities are also shifting toward operational intelligence and predictive maintenance functionality. Digitally enabled oxygen therapy systems capable of transmitting usage data, maintenance alerts, and patient compliance metrics are gaining traction among healthcare networks seeking improved treatment visibility and reduced servicing disruptions. These capabilities create downstream linkages with broader telehealth and remote care management ecosystems, positioning oxygen therapy equipment as part of integrated chronic disease management infrastructure rather than standalone respiratory hardware.

Energy efficiency and environmental considerations are becoming increasingly influential procurement variables as healthcare providers evaluate lifecycle operating costs and sustainability objectives. Manufacturers investing in lower-energy concentrator platforms, recyclable components, and extended service-life designs are likely to strengthen positioning within institutional procurement frameworks emphasizing long-term operational efficiency. Advanced derivative configurations supporting high-flow therapy, travel compatibility, and modular servicing are also expanding product differentiation opportunities across specialized patient populations.

Competitive Landscape Overview

The Oxygen Therapy Equipment competitive landscape remains moderately consolidated, with competition shaped by product reliability, service infrastructure, regulatory credibility, and distribution reach rather than pure manufacturing scale alone. Market participants increasingly differentiate themselves through portfolio breadth, installed-base servicing capabilities, and integration with broader respiratory care ecosystems. Competitive positioning is particularly influenced by the ability to support both institutional procurement and decentralized homecare delivery models without compromising operational responsiveness.

Basis of competition continues shifting toward lifecycle value creation rather than upfront acquisition pricing alone. Buyers increasingly evaluate suppliers according to maintenance continuity, consumable compatibility, remote diagnostics support, and training capabilities. This has strengthened the importance of long-term customer retention strategies and regional service networks. Consolidation activity is expected to remain selective and strategically targeted, particularly around companies possessing advanced portable technologies, digital integration capabilities, or specialized distribution infrastructure in underpenetrated regional markets.

Key Players

• Koninklijke Philips N.V.
• ResMed Inc.
• Invacare Corporation
• Drive DeVilbiss Healthcare
• CAIRE Inc.
• Inogen, Inc.
• Fisher & Paykel Healthcare Limited
• Teleflex Incorporated
• Drägerwerk AG & Co. KGaA
• Chart Industries, Inc.
• ICU Medical, Inc.
• Medtronic plc
• GE HealthCare Technologies Inc.
• Air Liquide Healthcare
• Linde plc
• Nidek Medical Products, Inc.
• O2 Concepts LLC
• GCE Group
• Precision Medical, Inc.
• Teijin Pharma Limited
• Besco Medical Limited
• Smiths Medical
• Hamilton Medical AG
• Yuwell Medical Equipment & Supply Co., Ltd.
• Tecno-Gaz S.p.A.

Recent Developments

In April 2026, ProSomnus Sleep Technologies received FDA Class II clearance for its RPMO₂ OSA Device integrating physiologic oxygen saturation monitoring with oral appliance therapy, reflecting continued convergence between connected respiratory monitoring and oxygen-related therapy platforms in sleep and home respiratory care markets.

In February 2026, Inogen reported expanded manufacturing and operational efficiency initiatives alongside portfolio strengthening measures aimed at accelerating profitability and supporting broader deployment of home-based oxygen therapy systems, reinforcing competitive pressure in the portable and stationary concentrator segments.

In June 2025, Inogen launched the Voxi 5 stationary oxygen concentrator for long-term and home-care applications, marking a strategic expansion beyond portable oxygen concentrators and increasing competition in the stationary oxygen delivery category.

In January 2025, CAIRE introduced the IntenOxy 5 stationary oxygen concentrator in the United States and Puerto Rico with planned expansion into Canada, strengthening supply availability and product penetration in long-term oxygen therapy settings.

In 2025, leading oxygen therapy equipment manufacturers increased investments in connected respiratory care ecosystems integrating cloud-based monitoring, remote compliance management, and home-care deployment models, accelerating the shift toward digitally enabled oxygen therapy management.

In 2025, manufacturers including ResMed and Philips Respironics expanded production optimization and regional assembly strategies to strengthen supply chain resilience and improve availability of oxygen therapy devices amid sustained global respiratory care demand.

In 2025, the oxygen therapy equipment market saw broader adoption of compact and low-noise stationary concentrators designed for home-care environments, reflecting changing purchasing preferences toward decentralized respiratory care and long-duration home oxygen therapy.

Methodology & Data Credibility

This Oxygen Therapy Equipment industry analysis is supported through a multi-layered research methodology combining bottom-up market modeling, cross-region demand validation, supply-side production assessment, and executive-level industry consultation. Market sizing frameworks incorporate equipment shipment analysis, procurement pattern assessment, installed-base evaluation, and healthcare utilization benchmarking across major regional markets.

Demand and supply validation processes include triangulation across hospital procurement trends, homecare deployment patterns, distributor feedback, regulatory documentation review, and respiratory disease treatment utilization analysis. Executive interviews were conducted with procurement directors, respiratory therapists, product managers, healthcare administrators, distribution executives, and manufacturing strategists to validate operational assumptions and competitive positioning patterns. Cross-region triangulation was applied to ensure consistency between utilization trends, reimbursement structures, and technology adoption behavior across mature and developing healthcare ecosystems.

Who Should Read This Report

This report is designed for enterprise decision-makers requiring strategic clarity on the evolving Oxygen Therapy Equipment Market structure and long-term investment outlook. CXOs can use the analysis to evaluate expansion priorities, portfolio positioning strategies, and operational risk exposure within respiratory care ecosystems. Strategy teams benefit from segmentation-level insight tied to reimbursement dynamics, procurement evolution, and technology transition pathways.

Investors and financial stakeholders can leverage the report to assess margin resilience, installed-base monetization opportunities, and competitive defensibility across different equipment categories and regional markets. Consultants and product portfolio leaders may use the analysis to evaluate market-entry feasibility, distribution optimization strategies, and product differentiation opportunities aligned with decentralized healthcare delivery models and chronic disease management expansion.

What This Report Delivers

This report delivers decision-oriented intelligence designed to support long-term strategic planning rather than short-term promotional positioning. The analysis provides deep segmentation assessment, procurement intelligence, competitive structure evaluation, and demand-side interpretation across institutional and homecare respiratory care environments. Emphasis is placed on operational realities shaping buyer behavior, pricing resilience, and technology replacement cycles.

The report also delivers proprietary insight into how healthcare decentralization, chronic respiratory disease expansion, and digital integration trends are restructuring oxygen therapy procurement economics. By combining supply-chain evaluation, reimbursement interpretation, and regional strategic analysis, the study enables leadership teams to identify scalable growth pathways, operational vulnerabilities, and high-priority investment areas across the global Oxygen Therapy Equipment Market.

Oxygen Therapy Equipment Market Report Segmentation

By Type

• Oxygen Concentrators
• Compressed Oxygen Cylinders
• Liquid Oxygen Systems
• Oxygen Masks and Accessories
• Portable Oxygen Therapy Devices

By Application

• Chronic Obstructive Pulmonary Disease
• Asthma Care

• Sleep Apnea Management

• Emergency and Critical Care
• Post-Surgical Recovery
• Other Respiratory Disorders

By End User

• Hospitals and Acute Care Centers
• Homecare Settings
• Ambulatory Surgical Centers
• Respiratory Clinics
• Rehabilitation Centers

By Region

• North America: United States, Canada
• Europe: Germany, United Kingdom, France, Italy, Spain, Rest of Europe
• Asia Pacific: China, India, Japan, South Korea, Australia, Southeast Asia, Rest of Asia Pacific
• Latin America: Brazil, Mexico, Rest of Latin America
• Middle East & Africa: GCC, South Africa, Rest of Middle East & Africa